Literature DB >> 16702106

Clinical and microbiological aspects of candidemia due to Candida parapsilosis in Brazilian tertiary care hospitals.

Ligia R Brito1, Thaís Guimarães, Marcio Nucci, Robert C Rosas, Leila Paula Almeida, Daniel A Da Matta, Arnaldo L Colombo.   

Abstract

In order to characterize the epidemiology, microbiology and outcome of candidemia due to Candida parapsilosis, we examined a database of 282 episodes of candidemia prospectively collected from four tertiary care hospitals in São Paulo, Brazil between March 2002 and February 2003, and compared the characteristics of patients with candidemia due to C. parapsilosis (n=64) with those caused by Candida albicans (n=107). C. parapsilosis candidemia was associated with neutropenia (p=0.005), tunneled central venous catheter (p=0.005) and cancer chemotherapy (p=0.03). By multivariate analysis, candidemia due to C. parapsilosis was associated with the presence of a tunneled central venous catheter (relative risk 3.71, 95% confidence interval 1.28-10.70). Except for a single isolate of C. parapsilosis that exhibited MIC >1 microg/ml to amphotericin B, no resistance was observed in 166 isolates tested against fluconazole, itraconazole, 5-flucytosine and amphotericin B. The caspofungin MIC values of C. parapsilosis isolates were significantly higher than those exhibited by C. albicans isolates (p<0.001). The overall mortality of patients with candidemia due to C. parapsilosis was significantly lower (45% vs. 62%, p=0.03). The association between C. parapsilosis candidemia and a tunneled central venous catheter supports the idea that the main mode of acquisition of C. parapsilosis is from an external source.

Entities:  

Mesh:

Year:  2006        PMID: 16702106     DOI: 10.1080/13693780500421476

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  24 in total

1.  Antifungal resistance to fluconazole and echinocandins is not emerging in yeast isolates causing fungemia in a Spanish tertiary care center.

Authors:  Laura Judith Marcos-Zambrano; Pilar Escribano; Carlos Sánchez; Patricia Muñoz; Emilio Bouza; Jesús Guinea
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

2.  Nosocomial bloodstream infections in Brazilian hospitals: analysis of 2,563 cases from a prospective nationwide surveillance study.

Authors:  Alexandre R Marra; Luis Fernando Aranha Camargo; Antonio Carlos Campos Pignatari; Teresa Sukiennik; Paulo Renato Petersen Behar; Eduardo Alexandrino Servolo Medeiros; Julival Ribeiro; Evelyne Girão; Luci Correa; Carla Guerra; Carlos Brites; Carlos Alberto Pires Pereira; Irna Carneiro; Marise Reis; Marta Antunes de Souza; Regina Tranchesi; Cristina U Barata; Michael B Edmond
Journal:  J Clin Microbiol       Date:  2011-03-16       Impact factor: 5.948

3.  Isolation and drug susceptibility of Candida parapsilosis sensu lato and other species of C. parapsilosis complex from patients with blood stream infections and proposal of a novel LAMP identification method for the species.

Authors:  Plinio Trabasso; Tetsuhiro Matsuzawa; Renata Fagnani; Yasunori Muraosa; Kenichiro Tominaga; Mariangela Ribeiro Resende; Katsuhiko Kamei; Yuzuru Mikami; Angelica Zaninelli Schreiber; Maria Luiza Moretti
Journal:  Mycopathologia       Date:  2014-12-07       Impact factor: 2.574

4.  Geographic distribution and antifungal susceptibility of the newly described species Candida orthopsilosis and Candida metapsilosis in comparison to the closely related species Candida parapsilosis.

Authors:  Shawn R Lockhart; Shawn A Messer; Michael A Pfaller; Daniel J Diekema
Journal:  J Clin Microbiol       Date:  2008-06-18       Impact factor: 5.948

Review 5.  Candida parapsilosis, an emerging fungal pathogen.

Authors:  David Trofa; Attila Gácser; Joshua D Nosanchuk
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

Review 6.  Candida parapsilosis is a significant neonatal pathogen: a systematic review and meta-analysis.

Authors:  Mohan Pammi; Linda Holland; Geraldine Butler; Attila Gacser; Joseph M Bliss
Journal:  Pediatr Infect Dis J       Date:  2013-05       Impact factor: 2.129

7.  Targeted gene deletion in Candida parapsilosis demonstrates the role of secreted lipase in virulence.

Authors:  Attila Gácser; David Trofa; Wilhelm Schäfer; Joshua D Nosanchuk
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

8.  A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility.

Authors:  Guillermo Garcia-Effron; Santosh K Katiyar; Steven Park; Thomas D Edlind; David S Perlin
Journal:  Antimicrob Agents Chemother       Date:  2008-04-28       Impact factor: 5.191

9.  Bloodstream infections due to Trichosporon spp.: species distribution, Trichosporon asahii genotypes determined on the basis of ribosomal DNA intergenic spacer 1 sequencing, and antifungal susceptibility testing.

Authors:  Thomas C Chagas-Neto; Guilherme M Chaves; Analy S A Melo; Arnaldo L Colombo
Journal:  J Clin Microbiol       Date:  2009-02-18       Impact factor: 5.948

10.  Successful treatment of Candida parapsilosis and Pseudomonas aeruginosa infection using medical and surgical management in an injecting drug user with mitral and aortic valve endocarditis: a case report.

Authors:  Hanady Daas; Fadi Abuhmaid; Marcus Zervos
Journal:  J Med Case Rep       Date:  2009-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.